Cerebrolysin vs Semax

Side-by-side comparison of Cerebrolysin, Semax — mechanism, dosing, half-life, side effects, and research status.

← Pick different peptides
Attribute Cerebrolysin Cerebrolysin (Porcine Brain-Derived Neuropeptide Mixture) Cognitive Semax Semax (Heptapeptide ACTH Analogue) Cognitive
Basics
Molecular type Neuropeptide MixtureACTH-Derived Neuropeptide
Amino acids —7
Molecular weight —813.9 Da
Half-life Short (hours)~minutes (nasal); longer CNS retention
Route(s) Intravenous (IV), IntramuscularIntranasal, Subcutaneous
Mechanism & Research
Primary mechanism Cerebrolysin's mechanism is attributed to its low-molecular-weight peptide fraction, which crosses the blood-brain barrier and exerts BDNF-like, NGF-like, and VEGF-like neurotrophic effects. It stimulates neuroplasticity… Semax's primary mechanism involves upregulation of brain-derived neurotrophic factor (BDNF) — a neurotrophin critical for neuronal survival, synaptic plasticity, and neurogenesis. In animal models, Semax increases BDNF m…
Research status Research Compound Research Compound
Evidence summary Cerebrolysin has one of the most extensive clinical research programmes of any nootropic compound, with over 100 controlled trials across Alzheimer's disease, stroke, TBI, and vascular dementia. Evidence is mixed across … Semax has been investigated in Russian clinical research since the 1980s. It has been approved in Russia as a drug for stroke, TBI, and cognitive decline. Western research interest has grown, but large RCTs meeting curre…
Protocol & Dosing
Typical dose 10–30 mL per session (IV); 5–10 mL IM200–600 mcg/day (intranasal)
Frequency Daily for 10–20 day courses1–2x daily
Duration 10–20 day IV course, repeated quarterly2–4 weeks cycles
Timing MorningMorning (or morning + midday); avoid evening to prevent sleep disruption
Safety
Common side effects
  • Injection site pain (IM)
  • Agitation or anxiety (initial — dose-dependent)
  • Headache
  • Dizziness
  • Nasal irritation
  • Mild stimulation/anxiety (dose-dependent)
  • Headache (initial)
  • Temporary appetite change
Contraindications
  • Epilepsy/status epilepticus (can lower seizure threshold)
  • Severe renal impairment
  • Known hypersensitivity to porcine products
  • Active psychiatric conditions (bipolar, schizophrenia)
  • Epilepsy/seizure disorders
  • Pregnancy
Anti-doping Not Prohibited Not Prohibited
Deeper reading
Related peptides Semax, Dihexa, Selank Selank, Dihexa, P21
Full profile Read full Cerebrolysin profile → Read full Semax profile →

Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.